{{Rsnum
|rsid=1859430
|Gene=IL9
|Chromosome=5
|position=135894824
|Orientation=plus
|GMAF=0.1699
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=IL9
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 63.7 | 36.3 | 0.0
| HCB | 94.2 | 5.8 | 0.0
| JPT | 79.6 | 20.4 | 0.0
| YRI | 49.0 | 42.9 | 8.2
| ASW | 42.1 | 50.9 | 7.0
| CHB | 94.2 | 5.8 | 0.0
| CHD | 94.5 | 5.5 | 0.0
| GIH | 70.3 | 27.7 | 2.0
| LWK | 50.5 | 44.0 | 5.5
| MEX | 78.9 | 19.3 | 1.8
| MKK | 49.4 | 38.5 | 12.2
| TSI | 61.8 | 32.4 | 5.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=20332709
|Title=Association analysis of polymorphisms in IL-3, IL-4, IL-5, IL-9 and IL-13 with Graves' disease
}}

{{PMID|18298822|OA=1
}} Association study in the 5q31-32 linkage region for schizophrenia using pooled DNA genotyping.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}